Merck Serono announced that the FDA has approved EMD Serono‘s GONAL-f RFF Redi-ject (recombinant follitropin alfa) injection, a disposable prefilled drug injector pen indicated for the subcutaneous ...
The Gonal-f ® RFF Redi-ject™ will be available in December 2013 in three pen sizes: 300 IU, 450 IU and 900 IU. For more information about the Gonal-f ® RFF Redi-ject™, please call Fertility Lifelines ...
Urofollitropin (Gonal -F FBM) is a human follicle-stimulating hormone, prescribed in combination with HCG hormone for infertility in women who have not responded to other therapy. It stimulates the ...
DARMSTADT, Germany — The Food and Drug Administration has approved a pre-filled injector pen made by EMD Serono for infertile women, the company said Friday. The drug maker — the U.S. subsidiary of ...
GONAL-f (follitropin alfa injection) is a recombinant human follicle-stimulating hormone (r-hFSH) approved for the treatment female infertility and a rare form of male infertility. Merck announced ...
GENEVA, Switzerland, July 16 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that the Japanese Ministry of Health, Labor and Welfare has granted approval to ...
President Donald Trump on Thursday announced that EMD Serono, a Massachusetts-based healthcare company, will lower the price of Gonal-f, a widely used fertility medication, as part of a broader ...
Merck KGaA, whose sales of fertility drugs have benefited from competitor supply problems, will now have even more of its Gonal-f fertility drug to sell. The German company said today that it has ...
IVF treatment with Ferring’s Menopur yields a significantly higher live birth rate than that achieved with Serono’s recombinant follicle stimulating hormone product Gonal F (follitropin alfa), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results